Treatment of patients with in-stent restenosis
- PMID: 19736076
Treatment of patients with in-stent restenosis
Abstract
Treatment of patients with in-stent restenosis (ISR) remains a technical challenge. This problem has been reduced since the advent of drug-eluting stents (DES), but continues to represent a significant burden during daily practice in interventional cardiology. Treatment of ISR after bare-metal stent implantation has evolved and currently DES constitute the intervention of choice. However, DES may also develop ISR. The best therapeutic alternative for patients suffering from ISR after DES implantation remains to be elucidated. This review will focus on treatment of patients with ISR emphasising currently available alternatives, technical issues, limitations and future perspectives.
Similar articles
-
Classification and current treatment options of in-stent restenosis. Present status and future perspectives.Herz. 2004 Mar;29(2):187-94. doi: 10.1007/s00059-004-2574-4. Herz. 2004. PMID: 15057440 Review.
-
Contemporary treatment of in-stent restenosis and the incidence of recurrent in-stent restenosis in the era of drug-eluting stents.Heart Lung Circ. 2007 Aug;16(4):269-73. doi: 10.1016/j.hlc.2007.02.089. Epub 2007 Apr 6. Heart Lung Circ. 2007. PMID: 17419097
-
Outcome differences with the use of drug-eluting stents for the treatment of in-stent restenosis of bare-metal stents versus drug-eluting stents.Am J Cardiol. 2009 Feb 15;103(4):491-5. doi: 10.1016/j.amjcard.2008.09.107. Am J Cardiol. 2009. PMID: 19195508
-
Coexistent in-stent restenosis, late incomplete stent apposition and mural thrombus in a zotarolimus-eluting stent.J Invasive Cardiol. 2008 Aug;20(8):423-5. J Invasive Cardiol. 2008. PMID: 18688068
-
Secondary revascularisation following intracoronary brachytherapy.EuroIntervention. 2009 May;5 Suppl D:D121-6. EuroIntervention. 2009. PMID: 19736060 Review.
Cited by
-
Associations Between Target Lesion Restenosis and Drug-Eluting Balloon Use: An Observational Study.Medicine (Baltimore). 2016 Jan;95(3):e2559. doi: 10.1097/MD.0000000000002559. Medicine (Baltimore). 2016. PMID: 26817908 Free PMC article.
-
Vascular restoration therapy and bioresorbable vascular scaffold.Regen Biomater. 2014 Nov;1(1):49-55. doi: 10.1093/rb/rbu005. Epub 2014 Oct 20. Regen Biomater. 2014. PMID: 26816624 Free PMC article. Review.
-
Current Management of In-Stent Restenosis.Korean Circ J. 2018 May;48(5):337-349. doi: 10.4070/kcj.2018.0103. Korean Circ J. 2018. PMID: 29737639 Free PMC article. Review.
-
Optical Coherence Tomography in In-Stent Restenosis: A Challenge Made Easier.Heart Views. 2019 Jan-Mar;20(1):28-31. doi: 10.4103/HEARTVIEWS.HEARTVIEWS_6_19. Heart Views. 2019. PMID: 31143385 Free PMC article.
-
Refractory In-Stent Restenosis: Improving Outcomes by Standardizing Our Approach.Curr Cardiol Rep. 2018 Oct 22;20(12):140. doi: 10.1007/s11886-018-1076-6. Curr Cardiol Rep. 2018. PMID: 30350271 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical